We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IHI icon
726
iShares US Medical Devices ETF
IHI
$3.38B
$726K 0.05%
+12,959
New +$725K
JILL icon
727
J. Jill
JILL
$283M
$726K 0.05%
+20,750
New +$636K
DFIN icon
728
Donnelley Financial Solutions
DFIN
$1.16B
$725K 0.05%
+12,156
New +$742K
YOU icon
729
Clear Secure
YOU
$5.28B
$724K 0.05%
38,682
-13,793
-26% -$250K
DAVA icon
730
Endava
DAVA
$156M
$723K 0.05%
+24,715
New +$733K
LASR icon
731
nLIGHT
LASR
$3.17B
$723K 0.05%
66,169
+217
+0.3% +$2.64K
ACA icon
732
Arcosa
ACA
$7.11B
$720K 0.05%
+8,636
New +$720K
RDW icon
733
Redwire
RDW
$3.25B
$719K 0.05%
100,317
+10,479
+12% +$50.4K
PLTR icon
734
Palantir
PLTR
$413B
$718K 0.05%
+28,328
New +$638K
COKE icon
735
Coca-Cola Consolidated
COKE
$12.8B
$717K 0.05%
+6,610
New +$612K
DORM icon
736
Dorman Products
DORM
$4.18B
$717K 0.05%
+7,834
New +$717K
PRCH icon
737
Porch Group
PRCH
$1.8B
$716K 0.05%
473,963
-105,547
-18% -$294K
CIVI
738
DELISTED
Civitas Resources
CIVI
$714K 0.05%
10,347
-2,344
-18% -$170K
ELAN icon
739
Elanco Animal Health
ELAN
$11.1B
$712K 0.05%
49,367
+16,519
+50% +$264K
AAN
740
DELISTED
The Aaron's Company Inc
AAN
$712K 0.05%
71,319
+52,538
+280% +$411K
BHE icon
741
Benchmark Electronics
BHE
$2.96B
$711K 0.05%
+18,028
New +$663K
ALLK
742
DELISTED
Allakos
ALLK
$710K 0.05%
710,146
-27,177
-4% -$32.3K
EHAB
743
DELISTED
Enhabit
EHAB
$710K 0.05%
+79,615
New +$761K
NAMS icon
744
NewAmsterdam Pharma
NAMS
$3.34B
$709K 0.05%
+36,906
New +$740K
HCAT icon
745
Health Catalyst
HCAT
$128M
$708K 0.05%
110,785
+99,616
+892% +$639K
BIIB icon
746
Biogen
BIIB
$30.7B
$707K 0.05%
3,048
-75
-2% -$16.3K
CNA icon
747
CNA Financial
CNA
$14.1B
$705K 0.05%
+15,301
New +$679K
GL icon
748
Globe Life
GL
$14.3B
$705K 0.05%
8,574
+1,731
+25% +$143K
PBPB
749
DELISTED
Potbelly
PBPB
$705K 0.05%
87,768
+1,647
+2% +$15.3K
SPHR icon
750
Sphere Entertainment
SPHR
$5.73B
$705K 0.05%
+20,122
New +$783K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.